US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.700
- -0.120-2.49%
Close Oct 18 16:00 ET
- 4.770
- +0.070+1.49%
Post 19:09 ET
139.17MMarket Cap-7424P/E (TTM)
4.840High4.689Low60.34KVolume4.780Open4.820Pre Close284.81KTurnover0.35%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High88.68P/B82.09MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM3.12%Amplitude3.110Historical Low4.720Avg Price1Lot Size
Telomir Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 3.38%1.47M | 296.75%1.92M | 361.52%3.94M | 121.44%1.08M | 308.64%954.15K | 1,935.76%1.43M | 482.94K | 518.36%854.15K | 487.1K | 233.5K |
| Selling and administrative expenses | 1,363.55%879.7K | 1,640.58%741.54K | 2,766.11%600.19K | 3,937.28%395.29K | 2,625.09%102.19K | 1,502.85%60.11K | --42.6K | 79.92%20.94K | --9.79K | --3.75K |
| -General and administrative expense | 1,363.55%879.7K | 1,640.58%741.54K | 2,766.11%600.19K | 3,937.28%395.29K | 2,625.09%102.19K | 1,502.85%60.11K | --42.6K | 79.92%20.94K | --9.79K | --3.75K |
| Research and development costs | -10.91%594.8K | 82.59%804.02K | 88.95%1.57M | -57.31%203.78K | 14.28%262.56K | 906.76%667.63K | --440.34K | 558.70%833.21K | --477.31K | --229.75K |
| Other operating expenses | ---- | --370.5K | --1.77M | --479.55K | --589.4K | --698.6K | ---- | ---- | ---- | ---- |
| Operating profit | -3.38%-1.47M | -296.75%-1.92M | -361.52%-3.94M | -121.44%-1.08M | -308.64%-954.15K | -1,935.76%-1.43M | -482.94K | -518.36%-854.15K | -487.1K | -233.5K |
| Net non-operating interest income expense | 120.55%25.49K | -4.34M | -1.64M | -761.82K | -757.17K | -124.05K | 0 | 0 | 0 | 0 |
| Non-operating interest income | --25.49K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --0 | --4.34M | --1.64M | --761.82K | --757.17K | --124.05K | --0 | --0 | --0 | --0 |
| Other net income (expense) | -7.49M | |||||||||
| Special income (charges) | ---- | ---- | ---7.49M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | --7.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 6.54%-1.45M | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | -2,112.81%-1.55M | -482.94K | -518.36%-854.15K | -487.1K | -233.5K |
| Income tax | ||||||||||
| Net income | 6.54%-1.45M | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | -2,112.81%-1.55M | -482.94K | -518.36%-854.15K | -487.1K | -233.5K |
| Net income continuous Operations | 6.54%-1.45M | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | -2,112.81%-1.55M | ---482.94K | -518.36%-854.15K | ---487.1K | ---233.5K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 6.54%-1.45M | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | -2,112.81%-1.55M | -482.94K | -518.36%-854.15K | -487.1K | -233.5K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 6.54%-1.45M | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | -2,112.81%-1.55M | -482.94K | -518.36%-854.15K | -487.1K | -233.5K |
| Basic earnings per share | 4.51%-0.05 | -1,310.18%-0.23 | -1,430.39%-0.4415 | -1,814.92%-0.315 | -632.89%-0.0578 | -2,113.06%-0.0524 | -0.0163 | -518.37%-0.0288 | -0.0165 | -0.0079 |
| Diluted earnings per share | 4.51%-0.05 | -1,310.18%-0.23 | -1,430.39%-0.4415 | -1,814.92%-0.315 | -632.89%-0.0578 | -2,113.06%-0.0524 | -0.0163 | -518.37%-0.0288 | -0.0165 | -0.0079 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data